Stay updated with breaking news from Timothy Eley. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001...
Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 -- Arbutus Biopharma Corporation , a clinical-stage biopharmaceutical company leveraging its...
Conference Call and Webcast to discuss the new data being presented at AASLD scheduled for 8:45 AM ET, Friday, November 4, 2022